|
Jan 4
|
3 High-Yield Dividend Stocks to Buy Now and Hold at Least a Decade
|
|
Jan 3
|
Bristol Myers Squibb to Present at J.P. Morgan’s 43rd Annual Healthcare Conference
|
|
Jan 3
|
Update: Market Chatter: Drug Companies to Raise Prices on 250 Branded Drugs in 2025
|
|
Jan 2
|
Bristol-Myers Squibb's (NYSE:BMY) investors will be pleased with their 2.4% return over the last five years
|
|
Dec 31
|
Corcept Submits Application for Another Cushing's Syndrome Drug
|
|
Dec 31
|
Is Bristol-Myers Squibb Company (BMY) Among the Best Pharma Dividend Stocks to Buy In 2024?
|
|
Dec 30
|
Is Bristol-Myers Squibb Co. (BMY) the Best Stock for 10 Years?
|
|
Dec 30
|
FDA approves BMS’ Opdivo Qvantig for solid tumour indications
|
|
Dec 29
|
Bristol-Myers Squibb (NYSE:BMY) Is Paying Out A Larger Dividend Than Last Year
|
|
Oct 11
|
Bristol Myers Squibb (BMY) Stock Falls Amid Market Uptick: What Investors Need to Know
|
|
Oct 11
|
Top Research Reports for Bristol-Myers, Arthur J. Gallagher & TC Energy
|
|
Oct 9
|
BMY Buoyed by Recent Regulatory Updates: How to Play the Stock?
|
|
Oct 9
|
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
|
|
Oct 7
|
Old Drug Repurposed for Schizophrenia Could Reap Alzheimer’s Windfall
|
|
Oct 5
|
Bristol-Myers Squibb Company (BMY): A Buzzing AI Health Stock to Add to Your Portfolio
|
|
Oct 5
|
These 4 Measures Indicate That Bristol-Myers Squibb (NYSE:BMY) Is Using Debt Reasonably Well
|
|
Aug 30
|
Bristol Myers Squibb (BMY) Advances But Underperforms Market: Key Facts
|
|
Aug 30
|
Exact Sciences (EXAS) Up 7.5% Since Last Earnings Report: Can It Continue?
|
|
Aug 29
|
Neurocrine Stock Down 19% on Mixed Schizophrenia Study Results
|
|
Aug 29
|
Repligen (RGEN) Down 13.1% Since Last Earnings Report: Can It Rebound?
|